Pricing Log in Create free account

DermTech, Inc. (DMTKQ) vs ENDRA Life Sciences Inc. (NDRA)

DermTech, Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.7M against $3.3M — 2.3× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −572.2%) and the higher return on invested capital (−539.9% vs −5,493.5%). Across the 14 metrics below, ENDRA Life Sciences Inc. leads on 8 and DermTech, Inc. on 6.

Valuation

Metric DMTKQ NDRA Diagnostics & Research median
P/E n/m n/m 35.56
P/S n/m 17.54 4.37
P/B n/m 0.99 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA 0.45 n/m 24.35
EV/Sales (2.49) 2.22 5.51
Earnings yield 0.00% (133.33%) (1.89%)
Free cash flow yield 0.00% (124.95%) (0.15%)

Profitability

Metric DMTKQ NDRA Diagnostics & Research median
Gross margin 8.51% 0.00% 50.89%
Operating margin (588.62%) 0.00% (8.57%)
Net margin (572.19%) 0.00% (6.37%)
Free cash flow margin (460.10%) 0.00% 0.00%
Return on equity (121.75%) (152.04%) (2.92%)
Return on assets (64.00%) (110.08%) (6.71%)
Return on invested capital (5,493.45%) (539.89%) 0.00%

Growth

Metric DMTKQ NDRA Diagnostics & Research median
Revenue growth (TTM) 9.71% — 7.69%
EPS growth (last fiscal year) 20.36% 84.32% 25.92%
Revenue growth, 5-year CAGR 44.33% — 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DMTKQ NDRA Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 3.53 7.10 2.02
Net debt to EBITDA 0.57 0.14 0.70

Dividend

Metric DMTKQ NDRA Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric DMTKQ NDRA Diagnostics & Research median
Market cap 3.29m 7.65m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack